Growth Metrics

LifeMD (LFMD) Depreciation & Amortization (CF) (2018 - 2025)

LifeMD filings provide 10 years of Depreciation & Amortization (CF) readings, the most recent being $256431.0 for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 77.7% to $256431.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $4.0 million, a 67.56% increase, with the full-year FY2025 number at $866000.0, down 86.03% from a year prior.
  • Depreciation & Amortization (CF) hit $256431.0 in Q4 2025 for LifeMD, down from $262747.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.8 million in Q2 2025 to a low of $10695.0 in Q4 2021.
  • Median Depreciation & Amortization (CF) over the past 5 years was $57666.0 (2023), compared with a mean of $399667.3.
  • Biggest five-year swings in Depreciation & Amortization (CF): grew 13.92% in 2023 and later surged 2628.17% in 2024.
  • LifeMD's Depreciation & Amortization (CF) stood at $10695.0 in 2021, then surged by 319.61% to $44877.0 in 2022, then increased by 28.5% to $57666.0 in 2023, then skyrocketed by 150.24% to $144302.0 in 2024, then soared by 77.7% to $256431.0 in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $256431.0 (Q4 2025), $262747.0 (Q3 2025), and $1.8 million (Q2 2025) per Business Quant data.